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Abstract 
Objective  To assess the risk of psychiatric disorders and suicide attempts in children with type 1 
diabetes and their healthy siblings. 
Research Design and Methods We performed a population-based case cohort study of 
individuals born in Sweden between 1973 and 2009. Children with type 1 diabetes (n=17,122) 
and their healthy siblings (n=18,847) were identified and followed until their 18
th 
birthday.
 
Their 
risk of psychiatric disorders was compared with matched controls.  
Results The risk of psychiatric morbidity in children with type 1 diabetes compared to the 
general population was tripled within 6 months after the onset of diabetes (hazard ratio, HR 3.0, 
95% confidence interval, CI 2.7-3.4) and doubled within the total observation period (HR 2.1, CI 
2.0-2.2). An increased risk was noted in suicide attempts (HR 1.7, CI 1.4-2.0) and in most 
categories of psychiatric disorders. The risk of psychiatric disorders in probands declined from 
HR 2.7 (CI 2.2-3.3) for those in the cohort born 1973-1986 to 1.9 (CI 1.8-2.0) in those born 
1997-2009. The risk for any psychiatric disorders among siblings of patients with type 1 diabetes 
was estimated to be HR 1.1 (CI 1.0-1.1) and there was no increased risk in any of the specific 
category of disorders. 
Conclusions Children with type 1 diabetes are at high risk of psychiatric disorders, which seems 
to be a consequence of the disease rather than due to a common familial etiology. The results 
support recommendations on comprehensive mental health surveillance in children with type 1 
diabetes, especially in recently diagnosed children.  
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For decades, children with type 1 diabetes have been assumed to be at risk for psychiatric 
disorders. (1) Much of this assertion is based on clinical observations. (2-4) Also, large 
epidemiological studies have shown increased risks of psychiatric disorders in other chronic 
pediatric diseases (5; 6), and it is reasonable to assume that such associations may also be present 
for type 1 diabetes. Another theory has been that the threat of serious complications and strict 
treatment regimen put high demand on children and their caregivers, which in turn increase the 
risk for psychiatric disorders. (7) Nevertheless, the psychiatric disorders among children with 
type 1 diabetes have not yet been properly tested in large samples. Previous studies on the effect 
of childhood type 1 diabetes on the development of psychopathology have only used small and 
highly selected clinical samples. (7-12) These studies have produced equivocal and inconclusive 
findings. For example, three studies reported a two to threefold increased rate of psychiatric 
disorders in children with type 1 diabetes compared to their peers, (7-9) whereas other reports 
showed that there is no association. (11; 12)  
Exploring the association between type 1 diabetes and risk of psychiatric disorders is of high 
importance for parents, pediatric endocrinologists and researchers and has implications for 
recommendations on care of children with type 1 diabetes. For example, are potential 
associations higher in connection with the onset of type 1 diabetes? Has the magnitude of the 
associations changed with changing treatment practice of type 1 diabetes during the last decades? 
The main aim of our study was to assess the risk of psychiatric disorders in children with type 1 
diabetes. To overcome limitations of previous studies we used Swedish registers with high 
coverage and prospectively collected information to study the risk of psychiatric disorders in a 
large, nationwide, population-based dataset. We hypothesized that children would be especially 
vulnerable to development of psychiatric disorders within a 6-month period after diagnosis of 
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type 1 diabetes. We also expected that secular changes in diabetes care and diagnostic practice in 
child psychiatry would influence the prevalence and risk of psychiatric disorders among children 
with type 1 diabetes. In addition, to investigate a possible mechanism behind the association 
between type 1 diabetes and psychiatric disorders we performed complementary analyses on the 
risk of psychiatric disorders among healthy siblings of probands. This enabled us to test the 
hypothesis that the association between psychiatric disorders and type 1 diabetes is caused by 
familial factors, where high risk of psychiatric disorders among healthy siblings of children with 
type 1 diabetes would support a familial effect.  
RESEARCH DESIGN AND METHODS 
Participants 
We used data from the Swedish Pediatric Quality Registry (SWEDIABKIDS), Swedish National 
Diabetes Register (NDR), and the Swedish National Patient Register (NPR) to identify patients 
(probands) born in Sweden from 1964 onward with onset of type 1 diabetes before 18 years of 
age. Since 2000, the SWEDIABKIDS records data from all Swedish pediatric diabetes centers 
reaching 99% national coverage in 2007. (13) In 1996, the NDR was initiated as a quality 
measure in diabetes care at a national level. (14) Annual reports on patients treated for diabetes 
are delivered nationwide by hospitals as well as outpatient and primary care health centers. NDR 
provides information on type of diabetes, date of onset and insulin regimen. The NPR contains 
data on somatic and psychiatric inpatient health care since 1973 and outpatient care since 2001. 
(15) 
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For every patient with childhood onset type 1 diabetes we randomly selected 100 controls 
(unexposed individuals) from the Total Population Register. Probands and unexposed individuals 
were matched by sex, year and county of birth. The unexposed individuals were required to be 
born in Sweden after 1972, not have diabetes of any type before the age of 18 years, and be alive 
and living in Sweden at the time of diagnosis of diabetes of matched proband. (Description of 
study design on Supplementary Figure S1). Probands were divided into cohorts born 1973-1986, 
1987-1996, and 1997-2009 based on the time of diagnosis of type 1 diabetes. These cohorts were 
chosen because they coincide with changes in ICD classification in Sweden (introduction of 
ICD-9 was 1987 and ICD-10 was in 1997). To investigate the mechanism behind the association 
between type 1 diabetes and childhood psychiatric disorders, we also studied psychiatric 
outcomes in full-siblings of the patients with type 1 diabetes (siblings of probands). Biological 
relationship with patients with type 1 diabetes was established through the Multi-Generation 
Register, which links children to their biological parents. (16) Healthy siblings of probands were 
defined as children of the same parents without a diagnosis of diabetes of any type before the age 
of 18. Similar to the comparisons between probands and unexposed, one hundred healthy control 
sibling pairs (unexposed siblings) were randomly selected and matched to each case-sibling pair 
by sex, year and county of birth of both siblings. Both subjects in the relative control pair were 
required to be free of a diabetes diagnosis of any type prior to the age of 18. (Supplementary 
Figure S2). 
Exposure 
Type 1 diabetes was defined as having such a diagnosis in the SWEDIABKIDS or NDR or an 
ICD code in the NPR (ICD-8: 250.00– 250.09; ICD-9: 250A–250X; ICD-10: E10). ICD-8 and 9 
do not distinguish between type 1 and type 2 diabetes, but in our age range (<18 years) these 
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codes identify type 1 diabetes with high positive predictive value as type 2 diabetes is rather 
infrequent in the Swedish population up 18 years of age.” (17) We excluded 70 children who 
were later re-diagnosed as having monogenic diabetes (not type 1 diabetes). Furthermore, 153 
patients were diagnosed with type 1 diabetes outside Sweden and therefore excluded from 
further analysis due to uncertain date of diagnosis and psychiatric morbidity prior to diabetes.  
Outcome variables 
Outcome variables related to psychiatric disorders were obtained from the NPR. The variables 
were defined in accordance with ICD classifications: 1) any psychiatric disorders (ICD-8 codes 
290-315; ICD-9 codes 290-319; ICD-10 codes F00-F99), 2) suicide attempt (ICD-8/ICD-9 codes 
E950-E959 or E980-E989; ICD-10 codes X60-X84 or Y10-Y34), 3) psychotic disorders (ICD-8 
codes 295, 297-299; ICD-9 codes 295, 297, 298; ICD-10 codes F20-F29), 4) mood disorders 
(ICD-8 codes 296, 300.4; ICD-9 codes 296, 300E, 311; ICD-10 codes F30-F39), 5) anxiety, 
dissociative, stress-related, somatoform disorders (ICD-8 code 300 except 300.4, codes 307; 
ICD-9 code 300 except 300.E, or 308-309; ICD-10 codes F40-F45, F48), 6) eating disorders 
(ICD-9 codes 307B, 307F; ICD-10 code F50), 7) psychoactive substance misuse (ICD-8 codes 
291, 303, 304; ICD-9 codes 291, 303, 304, 305A or 305X; ICD-10 codes F10-F19), 8) Attention 
deficit hyperactivity disorder (ADHD) (ICD-9 code 314; ICD-10 code F90), 9) Autism spectrum 
disorder (ASD) (ICD-9 code 299; ICD-10 code F84), 10) intellectual disability (ICD-8 codes 
310-315; ICD-9 codes 317-319; ICD-10 codes F70-F79), and 11) other behavioral disorders 
(ICD-9 codes 312-313; ICD-10 codes F91-F98).  
Covariates 
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Information on sociodemographic characteristics was obtained by linkage to the biological 
parents through the Multi-Generation Register. (16) Parental psychiatric morbidity was defined 
as at least one event of: psychiatric diagnosis (ICD-8 codes 290-315; ICD-9 codes 290-319; 
ICD-10 codes F00-F99) or suicide attempt (ICD-8/ICD-9 codes E950-E959; ICD-10 codes X60-
X84 in the NPR) or death by suicide (obtained from the Cause of Death Register). (18) Data on 
parental country of birth came from the Migration Register. Parental level of education was 
extracted from the Education Register, the LISA database (the longitudinal integration database 
for health insurance and labor market studies by Swedish acronym), and the Population Censuses 
from the years of 1970, 1975, and 1985. (19; 20) In all patients, the highest level of education 
obtained by either parent was used in the multivariate analyses. The Medical Birth Register 
provided data on perinatal factors. (21) 
Statistical analysis  
Baseline characteristics were compared between probands and controls by a chi
2
 test or Student t 
test for mean values (Supplementary Table S1). Because of baseline differences between groups, 
not fully controlled by matching, subsequent analyses were additionally adjusted for covariates. 
The risk of psychiatric disorders (outcome) related to diagnosis of type 1 diabetes (exposure) was 
estimated with Cox’s proportional-hazards model conditioned on the matching variables (sex, 
year and county of birth). Follow-up began on diagnosis of diabetes (the date of first dose of 
insulin) and ended with first reported event of the diagnosis of psychiatric disorder, emigration 
from Sweden, death, or end of the study period (31
st
 January 2010). Censoring dates of death or 
emigration were extracted from the Cause of Death Register and the Migration Register, 
respectively. (18; 22) To control for censored observations prevalence of psychiatric disorder 
was calculated by the Kaplan-Meier method. The prevalence of psychiatric disorders was 
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estimated for the 10-year period after the onset of diabetes. This enables further comparison of 
estimates between cohorts and previously reported clinical samples.  
Likewise, using the sibling data, we analyzed the relation between exposure (having a sibling 
with type 1 diabetes) and outcome of psychiatric disorders with Cox’s model. The sibling 
cohorts were observed since their birth to the end of observation defined as above. Similarly, 
siblings of controls were observed from birth. As a side note, this will automatically result in a 
slightly higher prevalence among the controls to probands compared to controls of siblings. A 
robust sandwich estimator function was used to adjust for family clusters. Missing data were not 
replaced by any method but categorized as “unknown” for analyses. Statistical analyses were 
undertaken with SAS software (version 9.3; Cary, NC, USA). The study was approved by the 
Regional Ethics Committee at Karolinska Institutet, Stockholm, Sweden. 
RESULTS 
Baseline characteristics 
The mean age at onset of type 1 diabetes was 9.3 years; SD: 4.5. The median follow-up time of 
the patients with type 1 diabetes was 5.8 (IQR 2.8-9.4) years.  
Baseline characteristics of probands with type 1 diabetes, their healthy siblings and their matched 
controls are presented in Supplementary Table 1. Parents of probands were more likely to be 
over 35 years of age at the time of child’s birth, have Scandinavian origin and upper secondary 
level of education compared to the parents of their peers. Probands seemed to more often be born 
moderate to late preterm (32 – 36 gestational age), with high birth weight (>3500g) and large for 
gestational age. In 403 (2.4%) probands psychiatric disorders were recognized before the onset 
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of type 1 diabetes, significantly more often than among controls in the same age (N=33928, 
2.0%). Subsequent analyses were adjusted to those discrepancies between groups.  
The risk for psychiatric disorders 
In total, psychiatric disorders were recognized in 1428 (8.3%) probands, of whom 259 had more 
than one disorder. After adjustment for sociodemograhic and perinatal factors, probands were 2.1 
times more likely to receive psychiatric diagnoses and 1.7 times more likely to attempt suicide 
than controls (table 1). Probands had an increased risk for mood disorders (hazard ratio, HR 2.0, 
95% CI 1.8 - 2.3), anxiety disorders (HR 1.6, CI 1.4 - 2.0), eating disorders (HR 2.2, CI 1.8 - 
2.6), substance misuse (HR 2.6, CI 2.4 - 2.9), attention deficit hyperactivity disorder (HR 1.5, CI 
1.3 - 2.7), behavioral disorders (HR 2.2, CI 2.0 - 2.4), autism spectrum disorder (HR 1.7, CI 1.4 - 
2.0), and intellectual disability (HR 1.8, CI 1.5 - 2.1) compared with healthy peers. 
Increased risk of suicidal attempts was significant only for diagnoses from inpatient (HR 1.8, CI 
1.5 - 2.2), but not for outpatient care (HR 1.4, CI 1.0 - 2.0; p=0.07). Other psychiatric diagnoses 
were significant for both in- and outpatient care (data not shown).  
Overall, risk of psychiatric disorders increased with age at onset of type 1 diabetes (age of onset 
< 7 years: HR 1.9, CI 1.7 to 2.0 vs age of onset > 12 years: HR 2.4, CI 2.1 - 2.6). The highest 
risk of psychiatric disorder in all age groups was noted within the first 6 months after diagnosis 
of type 1 diabetes and declined with time (table 2).  
Changes in the prevalence and risk of psychiatric disorders in type 1 diabetes during 1973-
2009 
The overall prevalence of psychiatric disorders in probands was 11.4% (95% CI, 10.8% - 12.0%) 
in 10 years after the onset of type 1 diabetes in the entire sample. When analyzed by cohort, the 
10-year prevalence of psychiatric disorders increased threefold over the period of the study 
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(Table 3). The prevalence was lowest in the cohort with onset of type 1 diabetes in 1973-1986 
(4.6%, 95% CI, 3.7% - 5.7%), when psychiatric diagnoses were based on the 8
th
 version of ICD 
classification. The prevalence of psychiatric disorders doubled in 1987-1996 with the 9
th
 version 
of ICD (8.4%, 95% CI, 7.5% - 9.4%). Introduction of ICD-10 resulted in further increase in 
prevalence of psychiatric disorders (15.3%; 95% CI, 14.4% - 16.3%) in 1997-2009. This was 
true for all groups of disorders. A similar trend was observed in the healthy controls, where the 
10-year prevalence of psychiatric disorders was 1.5 (95% CI, 1.5% - 1.6%), 3.1 (95% CI, 3.0% - 
3.1%), 8.7 (95% CI, 8.7% - 8.8%), respectively for ICD-8, ICD-9 and ICD-10. Interestingly, the 
risk of psychiatric disorders among probands in comparison to controls actually declined (HR 
2.7, CI 2.2 - 3.3 for ICD-8; HR 2.5, CI 2.6 - 2.7 for ICD-9; HR 1.9 CI 1.8 - 2.0 for ICD-10). This 
trend was particularly evident in suicide attempts, behavioral disorders and intellectual 
disabilities (Table 3). 
Siblings of patients with type 1 diabetes 
Psychiatric disorders were observed in 1059 (5.6%) siblings of probands and 191 of these 
children received two or more psychiatric diagnoses. The adjusted risk for childhood psychiatric 
disorders among healthy full siblings of a patient with type 1 diabetes was estimated at HR 1.1 
(CI 1.0 - 1.1); for suicide attempts the HR was 1.2 (CI 1.0 - 1.4; p=0.12). When analyses were 
conducted separately for different categories of psychiatric disorders, none of the categories were 
statistically significant (table 4).  
CONCLUSIONS 
This is the first large scale population-based study on risk for psychiatric disorders in children 
with type 1 diabetes. Our findings support previous clinical observations that these patients are at 
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increased risk for psychiatric morbidity. (3; 4) We found increased risks for different diagnostic 
categories of disorders suggesting that psychological assessment restricted to mood and anxiety 
disorders probably is too limited. (23) Furthermore, our findings offer valuable insight into the 
etiology of psychiatric comorbidity in type 1 diabetes. Lack of risk of psychiatric disorders 
among siblings of patients suggests that there is no shared genetic susceptibility between those 
conditions. (24) 
Results in relation to other studies 
Our findings provide robust evidence for psychiatric comorbidity in pediatric patients with type 
1 diabetes. Previous case-control studies have yielded inconsistent results, primarily due to 
insufficient power for dichotomous variables. (26-29)  
Results from this study confirm previous observations on high risk for psychiatric disorders 
within the first 6 months of diabetes. This may be related to a crisis reaction hampering 
adjustment to treatment requirements, but it may also involve poor disease control in the initial 
phase. (4) A recent study by Cameron at al. demonstrated that impaired mental state in children 
with new-onset type 1 diabetes may be attributed to the brain injury related to severe 
ketoacidosis. (25)  
Our data provide evidence for cohort effects in the prevalence and the risk of psychiatric 
disorders among children with type 1 diabetes. In our sample, the prevalence of psychiatric 
disorders 10 years after onset of type 1 diabetes tripled from 3.8% in those born 1973-1986 to 
16.7% for the cohort born 1997-2009. The 10-year prevalence was studied previously by Kovacs 
et al, who found that 47.6% from cohort diagnosed with type 1 diabetes between 1981-1984 
developed psychiatric disorders. (3) However, methodological discrepancies between register-
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based and case-series observational studies make comparison with this study difficult. Changes 
in diabetic care such as more demanding insulin regimens and higher responsibility of youths 
and their caregivers for treatment decisions could theoretically be an explanation for the 
increased psychological burden in patients with type 1 diabetes in recent years. But, similar 
trends among controls suggest that more general factors are responsible for the increase rates of 
psychiatric disorders. Most likely, this trend is related to changes in ICD classification and 
secular drift in diagnostic praxis. A meta-analysis showed that in more recent studies the 
differences in psychiatric symptoms between children with diabetes and controls were actually 
smaller than observed previously. (26) When we stratified our analysis on the time of diabetes 
diagnosis, we noted steady decline in the relative risk of psychiatric disorders among probands 
compared to controls. This suggests that advances in diabetes care made over the past four 
decades, such as the introduction of an intensive insulin treatment in children allowing more 
flexible lifestyle and dietary freedom compared to conventional insulin regimen, might be 
associated with the reduced risk of mental health problems.  
Implications 
We showed that psychiatric comorbidity in children with type 1 diabetes is more complex than 
previously thought. Diabetes increased risk for most categories of psychiatric disorders and 
almost one fifth of children with diabetes and psychiatric disorders had two or more psychiatric 
disorders. This supports existing recommendations of comprehensive care of children with type 
1 diabetes. (27) Regular screening for disorders with available simple measures (i.e mood and 
anxiety disorders) would be valuable. A close cooperation between pediatric diabetes teams and 
mental health professionals is needed to monitor the mental health in children with type 1 
diabetes.  
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Our findings have also implications for etiological research, as comorbidity between two 
diseases may result from common etiological risk factors. Shared genetic susceptibility has 
previously been proposed as a rationale for higher risk of autism spectrum disorders in type 1 
diabetes. (28) To assess whether this hypothesis may explain psychiatric comorbidity in type 1 
diabetes, we evaluated the risk of different groups of psychiatric disorders also in healthy 
siblings of children with type 1 diabetes. We expected that healthy siblings should have, similar 
to their brothers and sisters with diabetes, higher risk of psychiatric disorders than general 
population. Slightly higher risk of any psychiatric disorder was noted among the siblings. 
However, despite adequate power (>80% for HR=1.2) no increased risk was found in any 
specific category of psychiatric disorders that might share genetic susceptibility with type 1 
diabetes. These results suggest that associations between type 1 diabetes and psychiatric 
disorders are due to biological and/or psychological effects of diabetes (i.e., consistent with a 
causal effect) rather than common genetic risk factors or within family environmental factors. 
Strength and limitations 
Strengths of our study include large scale population-based design, prospectively collected data 
from nationwide registries, control for several possible confounders, follow-up period up to 
adulthood, definitions of outcome as diagnosed disorders justifying clinical intervention and 
analysis of genetically informed data on siblings. Nevertheless, our study does have some 
limitations related to register-based methodology. Children with type 1 diabetes are under the 
regular diabetological care. High risk of psychiatric diagnoses in this population may be biased 
by care-seeking attitudes of parents adjusted to high utilization of the health care system. Still, 
the results for healthy siblings do not suggest that families with diabetes were more likely to seek 
help for psychiatric care for their children. Furthermore, one may argue that diabetologists could 
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notice symptoms that otherwise would not have been recognized and initiated referral to mental 
health services and this diagnostic bias could account for higher rates of psychiatric disorders in 
children with type 1 diabetes. Lack of detailed clinical data was another limitation of the study. 
Non-compliance and persistent high level of glycated hemoglobin in type 1 diabetes is a risk 
factor for psychiatric co-morbidity and neurodevelopmental problems. (29-31) However, we had 
no data on metabolic control of disease since medical records were unavailable.  
Summary 
In summary, our results have important clinical implications. First, high risk of psychiatric 
disorders in children with type 1 diabetes highlights the need of mental health service as part of 
gold-standard medical management in this population, and psychological care should start from 
the date of diagnosis of diabetes. Second, our findings draw attention to the complexity of 
psychiatric disorders accompanying type 1 diabetes. Design of cost-effective algorithms aimed at 
identifying children at risk of having psychiatric comorbidity poses a challenge. Third, this 
report challenges the single-disease approach, which dominates the health systems, medical 
education, and clinical research. This attitude has recently been questioned and the need of 
comprehensive care has been recognized. (32) Although physical-mental health comorbidity is 
mostly attributed to the elderly, our study shows that the pediatric population is not free from 
such difficulties and child health care needs to rise up to this challenge.  
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Supplementary Table S1: Characteristics of patients with type 1 diabetes, their healthy siblings 
and matched controls. Data are no (%) of subjects. 
Supplementary Figure S1:  Flow diagram of study of patients with type 1 diabetes vs healthy 
(unexposed) individuals. Diagram includes detailed information on the excluded individuals. 
Supplementary Figure S2: Flow diagram of study of siblings patients with type 1 diabetes vs 
siblings of healthy individuals (unexposed siblings). Diagram includes detailed information on 
the excluded sibling pairs.  
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Table 1: Hazard ratios (95% CI) for psychiatric disorders in childhood and adolescence in 
relation to diagnosis of type 1 diabetes 
 Probands 
Unexposed 
individuals 
  
Event 
Patients with 
type 1 
diabetes 
(n= 17122) 
No (%) with 
outcome 
Control 
group 
(n= 1696611) 
No (%) with 
outcome 
Univariate Multivariate 
Hazard ratio 
(95% CI)* 
Hazard ratio 
(95% CI)** 
Any psychiatric disorder 1428 (8.3) 70483 (4.2) 2.1 (2.0 - 2.2) 2.1 (2.0 - 2.2) 
Suicide attempt 129 (0.8) 7427 (0.4) 1.7 (1.4 - 2.0) 1.7 (1.4 - 2.0) 
Psychotic disorders 7 (0.0) 791 (0.1) 0.9 (0.4 - 1.8) 0.9 (0.4 - 1.8) 
Mood disorders 210 (1.2) 10286 (0.6) 2.0 (1.8 - 2.3) 2.0 (1.8 - 2.3) 
Anxiety, dissociative, stress 
to related and somatoform 
disorders 
178 (1.0) 10737 (0.6) 1.6 (1.4 - 2.0) 1.6 (1.4 - 2.0) 
Eating disorders 102 (0.6) 4656 (0.3) 2.2 (1.8 - 2.7) 2.2 (1.8 - 2.6) 
Substance misuse 370 (2.2) 13997 (0.8) 2.6 (2.4 - 2.9) 2.6 (2.4 - 2.9) 
Attention-deficit 
hyperactivity disorders 
211 (1.2) 13575 (0.8) 1.5 (1.3 - 1.8) 1.5 (1.3 - 2.7) 
Other behavioural disorders 340 (2.0) 15477 (0.9) 2.2 (2.0 - 2.4) 2.2 (2.0 - 2.4) 
Autism spectrum disorders 114 (0.7) 6924 (0.4) 1.6 (1.4 - 2.0) 1.7 (1.4 - 2.0) 
Intellectual disability 127 (0.7) 7312 (0.4) 1.7 (1.4 - 2.4) 1.8 (1.5 - 2.1) 
 
*- Conditional analysis adjusted to age at the time of recruitment, sex, year and county of birth 
by matching; **- Multivariate Cox regression additionally adjusted for socio-economic factors 
(maternal/paternal age at child birth, maternal/paternal psychiatric history, maternal/paternal 
country of birth, level of education of higher educated parent), perinatal variables (gestational 
age, birth weight, being born small for gestational age, being born large for gestational age, 
Apgar score) and history of psychiatric disorders prior to the recruitment.
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Table 2: Hazard ratios (95% CI) for psychiatric disorders in relation to diagnosis of type 1 
diabetes stratified by age at onset and duration of type 1 diabetes.  
 
Age at onset of 
type 1 diabetes 
(years) 
Duration of type 1 diabetes (years) Total 
<0.5 0.5-4 >5 
<7 2.7 (1.9 - 3.7) 2.0 (1.7 - 2.3) 1.8 (1.6 - 2.0) 1.9 (1.7 - 2.0) 
7 - 11 3.3 (2.6 - 4.1) 1.9 (1.7 - 2.2) 2.1 (1.8 - 2.4) 2.1 (1.9 - 2.3) 
≥12  3.0 (2.5 - 3.6) 2.2 (1.9 - 2.5) 1.7 (0.8 - 3.5) 2.4 (2.1 - 2.6) 
Total 3.0 (2.7 - 3.4) 2.0 (1.9 - 2.2) 1.9 (1.7 - 2.1) 2.1 (2.0 - 2.2) 
 
Multivariate conditional analysis adjusted to age at the time of recruitment, sex, year and county 
of birth by matching and additionally adjusted for variables included in the model: socio-
economic factors (maternal/paternal age at child birth, maternal/paternal psychiatric history, 
maternal/paternal country of birth, level of education of higher educated parent), perinatal 
variables (gestational age, birth weight, being born small for gestational age, being born large for 
gestational age, Apgar score) and history of psychiatric disorders prior to the recruitment. 
Observations were censored for any psychiatric disorder diagnosed in previous follow-up period 
after onset of type 1 diabetes.  
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Table 3: The prevalence 10 years after diagnosis of type 1 diabetes and hazard ratios for psychiatric disorders by diabetes diagnosis 
cohort 
Measurement Prevalence, % (95% CI) Hazard ratio (95% CI)** 
Diagnosis cohort 1973-1986 1987-1996 1997-2009 1973-1986 1987-1996 1997-2009 
Any psychiatric disorder 3.8 (3.0 - 4.8) 8.8 (7.8 - 9.8) 16.7 (15.4 - 18.1) 2.7 (2.2 - 3.3) 2.5 (2.3 - 2.8) 1.9 (1.8 - 2.0) 
Suicide attempt 0.5 (0.2 - 0.9) 1.1 (0.8 - 1.6) 1.4 (1.0 - 1.9) 2.1 (1.4 - 3.2) 1.7 (1.3 - 2.2) 1.6 (1.3 - 2.1) 
Psychotic disorders 0.1 (0.0 - 0.1) 0.1 (0.0 - 0.4) 0.1 (0.0 - 0.3) 1.3 (0.3 - 5.1) 0.7 (0.2 - 2.9) 0.9 (0.3 - 2.7) 
Mood disorders 0.2 (0.0 - 0.5) 0.7 (0.5 - 1.1) 3.4 (2.7 - 4.3) 2.2 (1.0 - 5.2) 2.0 (1.6 - 2.6) 2.0 (1.7 - 2.4) 
Anxiety, dissociative, stress to 
related and somatoform 
disorders 
0.6 (0.3 - 1.0) 0.6 (0.4 - 0.9) 1.2 (0.9 - 1.7) 2.0 (0.9 - 4.4) 1.6 (1.2 - 2.2) 1.6 (1.4 - 1.9) 
Eating disorders 0.3 (0.1 - 0.7) 0.6 (0.4 - 0.9) 1.5 (1.1 - 2.1) 2.3 (1.1 - 4.7) 2.2 (1.6 - 3.1) 2.1 (1.7 - 2.8) 
Substance misuse 0.6 (0.4 - 1.1) 3.3 (2.7 - 4.0) 4.5 (3.8 - 5.5) 2.3 (1.6 - 3.3) 3.0 (2.5 - 3.5) 2.4 (2.1 - 2.8) 
Attention-deficit hyperactivity 
disorders 
0.0 (0.0 - 0.0) 1.0 (0.7 - 1.4) 3.2 (2.7 - 3.9) 1.0 (0.1 - 6.7) 2.3 (1.7 - 3.1) 1.4 (1.2 - 1.6) 
Other behavioural disorders 1.3 (0.8 - 1.9) 1.9 (1.5 - 2.5) 4.5 (3.9 - 5.3) 3.5 (2.3 - 5.2) 2.5 (2.0 - 3.1) 2.0 (1.8 - 2.3) 
Autism spectrum disorders* - 0.4 (0.2 - 0.7) 1.7 (1.3 - 2.1) - 1.7 (1.1 - 2.6) 1.7 (1.4 - 2.1) 
Intellectual disability 0.3 (0.1 - 0.6) 0.6 (0.4 - 1.0) 1.2 (1.0 - 1.6) 2.2 (1.2 - 4.2) 2.0 (1.4 - 2.9) 1.7 (1.4 - 2.1) 
 
*-  In ICD-8  autism spectrum disorders were classified as a schizophrenia in psychotic disorders.**- Multivariate adjusted hazard 
ratios (95% CI) for psychiatric disorders in children with type diabetes when comparing with matched unexposed individuals. 
Multivariate Cox regression adjusted for socio-economic factors (maternal/paternal age at child birth, maternal/paternal psychiatric 
history, maternal/paternal country of birth, level of education of higher educated parent), perinatal variables (gestational age, birth 
weight, being born small for gestational age, being born large for gestational age, Apgar score) and history of psychiatric disorders 
prior to the recruitment. 
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Table 4: Hazard ratios (95% CI)  for psychiatric disorders in childhood and adolescence when comparing siblings of patients with type 
1 diabetes and siblings of healthy individuals. 
 
Siblings of 
Probands 
Unexposed siblings   
Event 
Siblings of patients 
with type 1 diabetes 
(n= 18847) 
No (%) with 
outcome 
Siblings of healthy 
individuals 
(n= 1077951) 
No (%) with outcome 
Univariate Multivariate 
Hazard ratio 
(95% CI)* 
Hazard ratio 
(95% CI)** 
Any psychiatric disorder 1059 (5.6) 56366 (5.2) 1.1 (1.0 - 1.2) 1.1 (1.0 - 1.1) 
Suicide attempt 107 (0.6) 5152 (0.5) 1.2 (1.0 - 1.5) 1.2 (1.0 - 1.4) 
Psychotic disorders 7 (0.0) 520 (0.1) 0.8 (0.4 - 1.7) 0.8 (0.4 - 1.7) 
Mood disorders 117 (0.6) 6774 (0.6) 1.0 (0.8 - 1.2) 1.0 (0.8 - 1.2) 
Anxiety, dissociative, stress-
related and somatoform 
disorders 
122 (0.7) 7348 (0.7) 1.0 (0.8 - 1.2) 0.9 (0.8 - 1.1) 
Eating disorders 85 (0.5) 4592 (0.4) 1.1 (0.9 - 1.4) 1.1 (0.9 - 1.4) 
Substance misuse 193 (1.0) 9713 (0.9) 1.2 (1.0 - 1.4) 1.2 (1.0 - 1.3) 
Attention-deficit hyperactivity 
disorders 
151 (0.8) 8523 (0.8) 1.1 (1.0 - 1.3) 1.1 (0.9 - 1.2) 
Other behavioral disorders 265 (1.4) 13801 (1.3) 1.1 (1.0 - 1.3) 1.1 (1.0 - 1.2) 
Autism spectrum disorders 82 (0.4) 4845 (0.5) 1.0 (0.8 - 1.2) 1.0 (0.8 - 1.2) 
Intellectual disability 123 (0.7) 6164 (0.6) 1.2 (1.0 - 1.4) 1.2 (1.0 - 1.4) 
*- Conditional analysis adjusted to age at the time of recruitment, sex, year and county of birth by matching; **- Multivariate Cox 
regression additionally adjusted for socio-economic factors (maternal/paternal age at child birth, maternal/paternal psychiatric history, 
maternal/paternal country of birth, level of education of higher educated parent), perinatal variables (gestational age, birth weight, 
being born small for gestational age, being born large for gestational age, Apgar score. Confidence intervals for all outcomes except 
any psychiatric disorder include 1.0. 
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Supplementary Table S1: Characteristics of patients with type 1 diabetes, their healthy siblings and matched controls. Data are no (%) 
of subjects. 
 Probands 
Unexposed 
individuals 
P value Siblings of 
Probands 
Unexposed 
siblings 
P value 
 
Characteristics 
Patients with 
type 1 diabetes 
(n=17122) 
Healthy 
individuals  
(n=1696611) 
 Siblings of 
patients with 
type 1 diabetes 
(n= 18847) 
Siblings of 
healthy 
individuals  
(n= 1077951) 
 
Sex       
Male 9261 (54.1) 915255 (53.9)  9755 (51.8) 564167 (52.3)  
Female 7861 (45.9) 781356 (46.1) 0.7102 9092 (48.2) 513784 (47.7) 0.1152 
Maternal age at delivery 
(years) 
  
 
  
 
<35 14984 (87.5) 1497374 (88.3)  16589 (88.0) 964059 (89.4)  
≥35 2129 (12.4) 197201 (11.6)  2244 (11.9) 112954 (10.5)  
Unknown 9 (0.1) 2036 (0.1) 0.0002 14 (0.1) 938 (0.1) <0.0001 
Paternal age at delivery 
(years) 
  
 
  
 
<35 12675 (74.0) 1271546 (74.9)  14086 (74.7) 814229 (75.5)  
≥35 4363 (25.5) 413371 (24.4)  4743 (25.2) 262480 (24.4)  
Unknown 84 (0.5) 11694 (0.7) <0.0001 18 (0.1) 1242 (0.1) <0.0001 
Maternal psychiatric 
history 
  
 
  
 
Yes 1427 (8.3) 140957 (8.3)  1120 (5.9) 39321 (3.6)  
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No 15695 (91.7) 1555654 (91.7) 0.9239 17727 (94.1) 1038630 (96.4) <0.0001 
Paternal psychiatric 
history 
  
 
  
 
Yes 1214 (7.1) 125177 (7.4)  992 (5.3) 34474 (3.2)  
No 15908 (92.9) 1571434 (92.6) 0.1517 17855 (94.7) 1043477 (96.8) <0.0001 
Mothers region of birth       
Sweden 15562 (90.9) 1481231 (87.3)  16969 (90.0) 923785 (85.7)  
Scandinavia 754 (4.4) 66927 (3.9)  781 (4.1) 42059 (3.9)  
Europe 348 (2.0) 68580 (4.1)  377 (2.0) 45279 (4.2)  
Africa 165 (0.9) 14912 (0.9)  341 (1.8) 18192 (1.7)  
Asia 212 (1.2) 47974 (2.8)  287 (1.5) 38218 (3.6)  
Other 72 (0.4) 14951 (0.9)  78 (0.4) 9480 (0.9)  
Unknown 9 (0.1) 2036 (0.1) <0.0001 14 (0.1) 938 (0.1) <0.0001 
Fathers region of birth       
Sweden 15475 (90.4) 1462436 (86.2)  16943 (89.9) 912443 (84.7)  
Scandinavia 625 (3.7) 57241 (3.4)  648 (3.4) 36090 (3.4)  
Europe 397 (2.3) 79544 (4.7)  419 (2.2) 54934 (5.1)  
Africa 227 (1.3) 20100 (1.2)  418 (2.2) 21644 (2.0)  
Asia 228 (1.3) 48014 (2.8)  311 (1.7) 39921 (3.7)  
Other 86 (0.5) 17582 (1.0)  90 (0.5) 11677 (1.1)  
Unknown 84 (0.5) 11694 (0.7) <0.0001 18 (0.1) 1242 (0.1) <0.0001 
Parental education       
Primary and lower 
secondary 
982 (5.7) 101041 (6.0) 
 
954 (5.1) 58341 (5.4) 
 
Upper secondary 8337 (48.7) 804271 (47.4)  9049 (48.0) 490072 (45.5)  
Post-secondary 3081 (18.0) 302323 (17.9)  3374 (17.9) 195540 (18.1)  
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Postgraduate 4707 (27.6) 485837 (28.6)  5459 (30.0) 332088 (30.8)  
Unknown 15 (0.1) 3139 (0.2) <0.0001 11 (0.1) 1910 (37.2) <0.0001 
Psychiatric disorders 
prior to recruitment 
  
 
  
 
Yes 403 (2.4) 33928 (2.0)  - - - 
No 16719 (97.6) 1662683 (98.0) 0.001 - - - 
Perinatal and somatic 
indicators 
  
 
  
 
Gestational age (wk)       
<32 73 (0.4) 10431 (0.6)  150 (0.8) 7317 (0.7)  
32-36 973 (5.7) 83622 (4.9)  963 (5.1) 49470 (4.6)  
≥37 15807 (92.3) 1572576 (92.7)  17433 (92.5) 1000574 (92.8)  
Unknown 269 (1.6) 29982 (1.8) <0.0001 301 (1.6) 20590 (1.9) <0.0001 
Child small for 
gestational age (SGA) 
  
 
  
 
SGA 418 (2.4) 47204 (2.8)  428 (2.3) 25492 (2.4)  
No SGA 16080 (93.9) 1577638 (93.0)  17511 (92.9) 1001581 (92.9)  
Unknown 624 (3.6) 71769 (4.2) <0.0001 908 (4.8) 50878 (4.7) 0.5864 
Child large for 
gestational age (LGA) 
  
 
  
 
LGA 695 (4.1) 52611 (3.1)  830 (4.4) 36170 (3.4)  
No LGA 15803 (92.3) 1572231 (92.7)  17109 (90.8) 990903 (91.9)  
Unknown 624 (3.6) 71769 (4.2) <0.0001 908 (4.8) 50878 (4.7) <0.0001 
Birth weight (grams)       
<1500 62 (0.4) 8336 (0.5)  115 (0.6) 5998 (0.6)  
1500-2499 544 (3.1) 58356 (3.4)  615 (3.3) 33656 (3.1)  
2500-3499 7173 (41.9) 716745 (42.3)  7357 (39.0) 438331 (40.7)  
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≥3500 9076 (53.0) 882711 (52.0)  10443 (33.4) 578169 (53.6)  
Unknown 267 (1.6) 30463 (1.8) <0.0001 317 (1.7) 21797 (2.0) <0.0001 
Apgar score at 5 min 
after birth 
  
 
  
 
≥7  15634 (91.3) 1541636 (90.8)  17338 (92.0) 994305 (92.2)  
<7 162 (1.0) 16103 (1.0)  205 (1.1) 10829 (1.0)  
Unknown 1326 (7.7) 138872 (8.2) <0.0001 1304 (6.9) 72817 (6.8) 0.3449 
 
 
